Mr. Ju Zhao
(Chairman of the Advisory Board)
Mr. Zhao is the Chief Executive Officer of CMBI and Chief Investment Officer of CMB. He has led CMBI to become one of the most
renowned one-stop financial institutions in Hong Kong.
Mr. Hongbo Wang
Mr. Wang is the Chief Investment Officer and a key member of the investment committee of CMBI, responsible for CMBI’s overall
alternative investment strategies which include private equity investment.
Dr. Kexiang Zhou
Dr. Zhou is a Managing Director of CMBI, the Chief Investment Officer of CMBISZ and the head of CMBI’s healthcare investment
team. He has deep investment and industry expertise in the life science sector.
Mr. Guozheng Yu
Mr. Yu is a Managing Director of CMBI and a key member of the investment committee of CMBI SZ. He has a strong track record of
private equity investments in the green energy sector.
Mr. Rongfeng (Michael) Jiang
(Chief Executive Officer and Chairman of the Board)
Mr. Jiang is a Managing Director at CMBI and the general manager of CMBI’s asset management department and a key member of CMBI’s investment committee, responsible for CMBI’s China offshore alternative investment business which includes private equity investment.
Mr. Yao (Ethan) Ling
(Chief Financial Officer and Executive Director)
Mr. Ling is a Managing Director at CMBI and the head of investor relations of CMBI’s asset management business, where he is responsible for investor relations and capital raising for CMBI’s alternative investment products across private equity, private debt,
direct investment, coinvestment and public markets. He has led a number of transactions in China, including several sizeable
fundraisings with a focus on the new economy sectors and the technology-enabled space.
Ms. Di (Annie) Le
(Chief Operating Officer and Executive Director)
Ms. Le is a Vice President at CMBI. She is responsible for project investments of CMBI’s offshore funds. She has led the execution
of multiple transactions primarily in the new economy sectors in China, such as investments in JD Logistics, Inc. (HK: 02618),
Xiaomi Corporation (HK: 01810) and Tencent Music Entertainment Group (NYSE: TME). She has worked closely with CMBI’s
healthcare team and participated in transactions in the biotech sector and has also led multiple Southeast Asia deals with a China
Mr. Xiao (Harry) Zhang
(Business and Strategy Officer)
Mr. Zhang is an Associate at CMBI. He is responsible for private equity investment deal sourcing and analysis at CMBI AM. He has
managed and invested in multiple private equity investments in the new economy sectors in China, including Kingsoft Cloud
(NASDAQ: KC), Meitu (HK: 1357), Meituan (HK: 3690) and Nio Inc. (NASDAQ: NIO).
Ms. Qian Wu
Ms. Wu is a Managing Director at CMBI. She is responsible for product and sales of CMBI AM, and supervises the overall
operations and post-investment management of CMBI’s offshore investments. She has expertise in deal structuring, including
cross border transactions and transactions financing.
Ms. Xiaoxiao Qi
Ms. Qi is a Managing Director at CMBI. She focuses on private equity investments in the technology field, especially fintech. Her investment track record includes investments in Credo Technology (SH) Ltd., Chengdu Kelai Network Technology Co., Ltd. and Beijing Tongxinshang Technology Development Co., Ltd.
Mr. Lei Zhong
Mr. Zhong is the founding managing partner of M31 Capital and was a senior managing director and global partner at Fosun
International Limited (HK: 656).
Dr. Fangxiong Gong
Dr. Gong was the Chairman of J.P. Morgan China Investment Banking and Chairman of J.P.Morgan China Diversified Industry
Clients from 2009 to 2015 until his retirement.
Mr. Kim Lam Ng
Mr. Ng is the former national head of technology and media sectors for KPMG in China. Mr. Ng is a Member of American Institute
of Certified Public Accountants and a Chartered Global Management Accountant.
- Mr. Kim Lam Ng (Chairman)
- Mr. Lei Zhong
- Ms. Qian Wu
- Mr. Lei Zhong (Chairman)
- Dr. Fangxiong Gong
- Mr. Yao Ling
- Mr. Rongfeng Jiang (Chairman)
- Dr. Fangxiong Gong
- Mr. Kim Lam Ng
- 2022-03-17 Memorandum and Articles of Association of the Company ENG CHN
- 2022-03-17 Terms of Reference of the Audit Committee ENG CHN
- 2022-03-17 Terms of Reference of the Remuneration Committee ENG CHN
- 2022-03-17 Terms of Reference of the Nomination Committee ENG CHN
- 2022-03-17 Procedures for Shareholders to Propose a Person for Election as a Director ENG CHN